Unit 2: Cardiovascular Laboratory Markers as Predictors of Heart Disease Flashcards
1
Q
Laboratory Markers as Predictors of Heart Disease
A
> Lipid Profile: requires fasting
- Cholesterol
- HDLs
- LDLs
- Triglycerides
> Nonspecific Markers:
- Glucose
- Homocysteine
- C-reactive protein
- Coagulation studies (platelets, fibrinogen levels, PT, PTT, INR)
2
Q
Cholesterol
A
less than 200 mg/dL
- lipid necessary for synthesis of hormones and cell walls
- available through ingestion of animal products (meat) and through synthesis in the liver
- not soluble in blood; combines w/ proteins to form lipoproteins (LDLs, HDLs) to facilitate transport through the vascular system
3
Q
Low-Density Lipoproteins (LDLs)
A
- less than 100 mg/dL (< 100 mg/dL)
- transports cholesterol into the cell
- can deposit it on the walls of the arterial vessels
- elevated levels (> 100mg/dL) = increased risk of heart disease
4
Q
High-Density Lipoproteins (HDLs)
A
- > 40-60 mg/dL
- protective lipoprotein
- transports cholesterol away from the cells to the liver for excretion
- decreased levels ( < 40 to 60 mg/dL) = risk for heart disease
5
Q
Total Cholesterol Level
A
includes LDLs and HDLs
- Normal: 200 mg/dL or less
- Increased = risk factor for atherosclerotic vessel disease
6
Q
Triglyceride Level
A
- less than 150 mg/dL (<150 mg/dL)
- store unused ingested calories in fat cells, which may be later released as an energy source between meals
- increased levels (> 150 mg/dL) = risk factor for heart disease
7
Q
Glucose
A
- 65-99 mg/dl
- diabetes and hyperglycemia are risk factors for CVD
8
Q
Homocysteine
A
- 4-10.8 mm/L
- increased = risk for heart disease
- amino acid
- can damage lining of arterial walls, causing clot formation
- decreased dietary intake of folic acid and B vitamins is associated with increased levels of homocysteine
9
Q
C-reactive Protein
A
Normal= 0
- not specific for cardiac disease
- elevated levels = increased production of c-reactive protein in the liver secondary to systemic inflammation
- only present hen inflammation is present
10
Q
Platelets
A
150,000-400,000
- increased = increased risk of atherosclerotic heart disease
- used for screening purposes
11
Q
Fibrinogen Levels
A
200-400 mg/dL
- increased = risk of atherosclerotic heart disease
- used for screening purposes
12
Q
Prothrombin Time (PT)
A
10-13 seconds
- measured in patients with increased risk of clot formation (a-fib)
- used to monitor anticoagulation therapy
13
Q
Partial Thromboplastin Time (PTT)
A
25-35 seconds
- measured in patients with increased risk of clot formation
- used to monitor anticoagulation therapy
14
Q
International normalized ratio (INR)
A
< 2.0
- measured in patient with increased risk of clot formation
- used to monitor anticoagulation therapy